Role of mitochondrial protein quality control in oxidative stress-induced neurodegenerative diseases

Current Alzheimer Research

Volumn 13, Issue 2, 2016, Pages 164-173

  Cenini, Giovanna ^a   Voos, Wolfgang ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Alzheimer disease; Mitochondrial protein quality control (mtPQC); Oxidative stress; Parkinson disease

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHAPERONE; FREE RADICAL; MITOCHONDRIAL PROTEIN; PROTEIN AGGREGATE; PROTEINASE; REACTIVE OXYGEN METABOLITE;

AEROBIC METABOLISM; AGING; ARTICLE; CELL ORGANELLE; DEGENERATIVE DISEASE; ENVIRONMENTAL STRESS; HEAT SHOCK; HOMEOSTASIS; HUMAN; MAMMAL CELL; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; QUALITY CONTROL; ANIMAL; METABOLISM; PHYSIOLOGY;

ANIMALS; HUMANS; MITOCHONDRIAL PROTEINS; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS;

EID: 84959342156     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205012666150921103213     Document Type: Article

References (144)

1. Butterfield DA, Stadtman ER. Protein oxidation processes in aging brain. Adv Cell Aging Gerontol 2: 161-91 (1997).
2. Grune T, Reinheckel T, Davies KJ. Degradation of oxidized proteins in mammalian cells. FASEB J 11(7): 526-34 (1997).
3. Grune T, Merker K, Sandig G, Davies KJ. Selective degradation of oxidatively modified protein substrates by the proteasome. Biochem Biophys Res Commun 305(3): 709-18 (2003).
4. Voos W. Chaperone-protease networks in mitochondrial protein homeostasis. Biochim Biophys Acta 1833(2): 388-99 (2013).
5. Baker MJ, Tatsuta T, Langer T. Quality control of mitochondrial proteostasis. Cold Spring Harb Perspect Biol 3(7): (2011).
6. Voos W. Mitochondrial protein homeostasis: the cooperative roles of chaperones and proteases. Res Microbiol 160(9): 718-25 (2009).
7. Young L, Leonhard K, Tatsuta T, Trowsdale J, Langer T. Role of the ABC transporter Mdl1 in peptide export from mitochondria. Science 291(5511): 2135-8 (2001).
8. Wagner I, Arlt H, van Dyck L, Langer T, Neupert W. Molecular chaperones cooperate with PIM1 protease in the degradation of misfolded proteins in mitochondria. EMBO J 13(21): 5135-45 (1994).
9. Gottesman S, Wickner S, Maurizi MR. Protein quality control: triage by chaperones and proteases. Genes Dev 11(7): 815-23 (1997).
10. Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell 120(4): 483-95 (2005).
11. Baker BM, Haynes CM. Mitochondrial protein quality control during biogenesis and aging. Trends Biochem Sci 36(5): 254-61 (2011).
12. Wiedemann N, Frazier AE, Pfanner N. The protein import machinery of mitochondria. J Biol Chem 279(15): 14473-6 (2004).
13. Baker MJ, Palmer CS, Stojanovski D. Mitochondrial protein quality control in health and disease. Br J Pharmacol 171(8): 1870-89.
14. Powers ET, Balch WE. Diversity in the origins of proteostasis networks--a driver for protein function in evolution. Nat Rev Mol Cell Biol 14(4): 237-48 (2013).
15. Craig EA, Kramer J, Kosic-Smithers J. SSC1, a member of the 70-kDa heat shock protein multigene family of Saccharomyces cerevisiae, is essential for growth. Proc Natl Acad Sci USA 84(12): 4156-60 (1987).
16. Strub A, Lim JH, Pfanner N, Voos W. The mitochondrial protein import motor. Biol Chem 381(9-10): 943-9 (2000).
17. Mayer MP. Hsp70 chaperone dynamics and molecular mechanism. Trends Biochem Sci 38(10): 507-14 (2013).
18. Craig EA, Huang P, Aron R, Andrew A. The diverse roles of Jproteins, the obligate Hsp70 co-chaperone. Rev Physiol Biochem Pharmacol 156: 1-21 (2006).
19. Miao B, Davis JE, Craig EA. Mge1 functions as a nucleotide release factor for Ssc1, a mitochondrial Hsp70 of Saccharomyces cerevisiae. J Mol Biol 265(5): 541-52 (1997).
20. Liu Y, Liu W, Song XD, Zuo J. Effect of GRP75/mthsp70/PBP74/mortalin overexpression on intracellular ATP level, mitochondrial membrane potential and ROS accumulation following glucose deprivation in PC12 cells. Mol Cell Biochem 268(1-2): 45-51 (2005).
21. Xu L, Voloboueva LA, Ouyang Y, Emery JF, Giffard RG. Overexpression of mitochondrial Hsp70/Hsp75 in rat brain protects mitochondria, reduces oxidative stress, and protects from focal ischemia. J Cereb Blood Flow Metab 29(2): 365-74 (2009).
22. Qu M, Zhou Z, Xu S, Chen C, Yu Z, Wang D. Mortalin overexpression attenuates beta-amyloid-induced neurotoxicity in SH-SY5Y cells. Brain Res 1368: 336-45 (2011).
23. E Q, Liu X, Liu Y, Liu W, Zuo J. Over-expression of GRP75 inhibits liver injury induced by oxidative damage. Acta Biochim Biophys Sin (Shanghai) 45(2): 129-34 (2013).
24. Williamson CL, Dabkowski ER, Dillmann WH, Hollander JM. Mitochondria protection from hypoxia/reoxygenation injury with mitochondria heat shock protein 70 overexpression. Am J Physiol Heart Circ Physiol 294(1): H249-56 (2008).
25. Voloboueva LA, Duan M, Ouyang Y, Emery JF, Stoy C, Giffard RG. Overexpression of mitochondrial Hsp70/Hsp75 protects astrocytes against ischemic injury in vitro. J Cereb Blood Flow Metab 28(5): 1009-16 (2008).
26. Tai-Nagara I, Matsuoka S, Ariga H, Suda T. Mortalin and DJ-1 coordinately regulate hematopoietic stem cell function through the control of oxidative stress. Blood 123(1): 41-50 (2014).
27. Marada A, Allu PK, Murari A, PullaReddy B, Tammineni P, Thiriveedi VR, et al. Mge1, a nucleotide exchange factor of Hsp70, acts as an oxidative sensor to regulate mitochondrial Hsp70 function. Mol Biol Cell 24(6): 692-703 (2013).
28. Cheng MY, Hartl FU, Martin J, Pollock RA, Kalousek F, Neupert W, et al. Mitochondrial heat-shock protein hsp60 is essential for assembly of proteins imported into yeast mitochondria. Nature 337(6208): 620-5 (1989).
29. Rospert S, Looser R, Dubaquie Y, Matouschek A, Glick BS, Schatz G. Hsp60-independent protein folding in the matrix of yeast mitochondria. EMBO J 15(4): 764-74 (1996).
30. Hartl FU, Bracher A, Hayer-Hartl M. Molecular chaperones in protein folding and proteostasis. Nature 475(7356): 324-32 (2011).
31. Bender T, Lewrenz I, Franken S, Baitzel C, Voos W. Mitochondrial enzymes are protected from stress-induced aggregation by mitochondrial chaperones and the Pim1/LON protease. Mol Biol Cell 22(5): 541-54 (2011).
32. Walter S. Structure and function of the GroE chaperone. Cell Mol Life Sci 59(10): 1589-97 (2002).
33. Reading DS, Hallberg RL, Myers AM. Characterization of the yeast HSP60 gene coding for a mitochondrial assembly factor. Nature 337(6208): 655-9 (1989).
34. Bross P, Naundrup S, Hansen J, Nielsen MN, Christensen JH, Kruhoffer M, et al. The Hsp60-(p.V98I) mutation associated with hereditary spastic paraplegia SPG13 compromises chaperonin function both in vitro and in vivo. J Biol Chem 283(23): 15694-700 (2008).
35. Ghosh JC, Siegelin MD, Dohi T, Altieri DC. Heat shock protein 60 regulation of the mitochondrial permeability transition pore in tumor cells. Cancer Res 70(22): 8988-93 (2010).
36. Mitsumoto A, Takeuchi A, Okawa K, Nakagawa Y. A subset of newly synthesized polypeptides in mitochondria from human endothelial cells exposed to hydroperoxide stress. Free Radic Biol Med 32(1): 22-37 (2002).
37. Sarangi U, Singh MK, Abhijnya KV, Reddy LP, Prasad BS, Pitke VV, et al. Hsp60 chaperonin acts as barrier to pharmacologically induced oxidative stress mediated apoptosis in tumor cells with differential stress response. Drug Target Insights 7: 35-51 (2013).
38. Uccelletti D, Farina F, Pinton P, Goffrini P, Mancini P, Talora C, et al. The Golgi Ca2+-ATPase KlPmr1p function is required for oxidative stress response by controlling the expression of the heatshock element HSP60 in Kluyveromyces lactis. Mol Biol Cell 16(10): 4636-47 (2005).
39. Cabiscol E, Belli G, Tamarit J, Echave P, Herrero E, Ros J. Mitochondrial Hsp60, resistance to oxidative stress, and the labile iron pool are closely connected in Saccharomyces cerevisiae. J Biol Chem 277(46): 44531-8 (2002).
40. Oksala NK, Ekmekci FG, Ozsoy E, Kirankaya S, Kokkola T, Emecen G, et al. Natural thermal adaptation increases heat shock protein levels and decreases oxidative stress. Redox Biol 3: 25-8 (2014).
41. Fratelli M, Demol H, Puype M, Casagrande S, Eberini I, Salmona M, et al. Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes. Proc Natl Acad Sci U S A 99(6): 3505-10 (2002).
42. Cechetto JD, Gupta RS. Immunoelectron microscopy provides evidence that tumor necrosis factor receptor-associated protein 1 (TRAP-1) is a mitochondrial protein which also localizes at specific extramitochondrial sites. Exp Cell Res 260(1): 30-9 (2000).
43. Felts SJ, Owen BA, Nguyen P, Trepel J, Donner DB, Toft DO. The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties. J Biol Chem 275(5): 3305-12 (2000).
44. Pearl LH, Prodromou C. Structure and mechanism of the Hsp90 molecular chaperone machinery. Annu Rev Biochem 75: 271-94 (2006).
45. Costantino E, Maddalena F, Calise S, Piscazzi A, Tirino V, Fersini A, et al. TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells. Cancer Lett 279(1): 39-46 (2009).
46. Kang BH, Plescia J, Dohi T, Rosa J, Doxsey SJ, Altieri DC. Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network. Cell 131(2): 257-70 (2007).
47. Sciacovelli M, Guzzo G, Morello V, Frezza C, Zheng L, Nannini N, et al. The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase. Cell Metab 17(6): 988-99 (2013).
48. Im CN, Lee JS, Zheng Y, Seo JS. Iron chelation study in a normal human hepatocyte cell line suggests that tumor necrosis factor receptor-associated protein 1 (TRAP1) regulates production of reactive oxygen species. J Cell Biochem 100(2): 474-86 (2007).
49. Masuda Y, Shima G, Aiuchi T, Horie M, Hori K, Nakajo S, et al. Involvement of tumor necrosis factor receptor-associated protein 1 (TRAP1) in apoptosis induced by beta-hydroxyisovalerylshikonin. J Biol Chem 279(41): 42503-15 (2004).
50. Hua G, Zhang Q, Fan Z. Heat shock protein 75 (TRAP1) antagonizes reactive oxygen species generation and protects cells from granzyme M-mediated apoptosis. J Biol Chem 282(28): 20553-60 (2007).
51. Montesano Gesualdi N, Chirico G, Pirozzi G, Costantino E, Landriscina M, Esposito F. Tumor necrosis factor-associated protein 1 (TRAP-1) protects cells from oxidative stress and apoptosis. Stress 10(4): 342-50 (2007).
52. Baqri RM, Pietron AV, Gokhale RH, Turner BA, Kaguni LS, Shingleton AW, et al. Mitochondrial chaperone TRAP1 activates the mitochondrial UPR and extends healthspan in Drosophila. Mech Ageing Dev 141-142C: 35-45 (2014).
53. Suzuki CK, Suda K, Wang N, Schatz G. Requirement for the yeast gene LON in intramitochondrial proteolysis and maintenance of respiration. Science 264(5161): 891 (1994).
54. Lu B, Lee J, Nie X, Li M, Morozov YI, Venkatesh S, et al. Phosphorylation of human TFAM in mitochondria impairs DNA binding and promotes degradation by the AAA+ Lon protease. Mol Cell 49(1): 121-32 (2013).
55. Venkatesh S, Lee J, Singh K, Lee I, Suzuki CK. Multitasking in the mitochondrion by the ATP-dependent Lon protease. Biochim Biophys Acta 1823(1): 56-66 (2012).
56. Cha SS, An YJ, Lee CR, Lee HS, Kim YG, Kim SJ, et al. Crystal structure of Lon protease: molecular architecture of gated entry to a sequestered degradation chamber. EMBO J 29(20): 3520-30 (2010).
57. Bota DA, Ngo JK, Davies KJ. Downregulation of the human Lon protease impairs mitochondrial structure and function and causes cell death. Free Radic Biol Med 38(5): 665-77 (2005).
58. Bota DA, Davies KJ. Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism. Nat Cell Biol 4(9): 674-80 (2002).
59. Watabe S, Kohno H, Kouyama H, Hiroi T, Yago N, Nakazawa T. Purification and characterization of a substrate protein for mitochondrial ATP-dependent protease in bovine adrenal cortex. J Biochem 115(4): 648-54 (1994).
60. Wang N, Gottesman S, Willingham MC, Gottesman MM, Maurizi MR. A human mitochondrial ATP-dependent protease that is highly homologous to bacterial Lon protease. Proc Natl Acad Sci U S A 90(23): 11247-51 (1993).
61. Amerik A, Petukhova GV, Grigorenko VG, Lykov IP, Yarovoi SV, Lipkin VM, et al. Cloning and sequence analysis of cDNA for a human homolog of eubacterial ATP-dependent Lon proteases. FEBS Lett 340(1-2): 25-8 (1994).
62. Luciakova K, Sokolikova B, Chloupkova M, Nelson BD. Enhanced mitochondrial biogenesis is associated with increased expression of the mitochondrial ATP-dependent Lon protease. FEBS Lett 444(2-3): 186-8 (1999).
63. Hori O, Ichinoda F, Tamatani T, Yamaguchi A, Sato N, Ozawa K, et al. Transmission of cell stress from endoplasmic reticulum to mitochondria: enhanced expression of Lon protease. J Cell Biol 157(7): 1151-60 (2002).
64. Bender T, Leidhold C, Ruppert T, Franken S, Voos W. The role of protein quality control in mitochondrial protein homeostasis under oxidative stress. Proteomics 10(7): 1426-43 (2010).
65. Bota DA, Van Remmen H, Davies KJ. Modulation of Lon protease activity and aconitase turnover during aging and oxidative stress. FEBS Lett 532(1-2): 103-6 (2002).
66. Ngo JK, Davies KJ. Mitochondrial Lon protease is a human stress protein. Free Radic Biol Med 46(8): 1042-8 (2009).
67. Luce K, Osiewacz HD. Increasing organismal healthspan by enhancing mitochondrial protein quality control. Nat Cell Biol 11(7): 852-8 (2009).
68. Bayot A, Gareil M, Chavatte L, Hamon MP, L’Hermitte-Stead C, Beaumatin F, et al. Effect of Lon protease knockdown on mitochondrial function in HeLa cells. Biochimie 100: 38-47 (2014).
69. Stanyer L, Jorgensen W, Hori O, Clark JB, Heales SJ. Inactivation of brain mitochondrial Lon protease by peroxynitrite precedes electron transport chain dysfunction. Neurochem Int 53(3-4): 95-101 (2008).
70. de Sagarra MR, Mayo I, Marco S, Rodriguez-Vilarino S, Oliva J, Carrascosa JL, et al. Mitochondrial localization and oligomeric structure of HClpP, the human homologue of E. coli ClpP. J Mol Biol 292(4): 819-25 (1999).
71. Yu AY, Houry WA. ClpP: a distinctive family of cylindrical energy-dependent serine proteases. FEBS Lett 581(19): 3749-57 (2007).
72. Jennings LD, Lun DS, Medard M, Licht S. ClpP hydrolyzes a protein substrate processively in the absence of the ClpA ATPase: mechanistic studies of ATP-independent proteolysis. Biochemistry 47(44): 11536-46 (2008).
73. Corydon TJ, Wilsbech M, Jespersgaard C, Andresen BS, Borglum AD, Pedersen S, et al. Human and mouse mitochondrial orthologs of bacterial ClpX. Mamm Genome 11(10): 899-905 (2000).
74. Baker TA, Sauer RT. ClpXP, an ATP-powered unfolding and protein-degradation machine. Biochim Biophys Acta 1823(1): 15-28 (2012).
75. van Dyck L, Dembowski M, Neupert W, Langer T. Mcx1p, a ClpX homologue in mitochondria of Saccharomyces cerevisiae. FEBS Lett 438(3): 250-4 (1998).
76. Bross P, Andresen BS, Knudsen I, Kruse TA, Gregersen N. Human ClpP protease: cDNA sequence, tissue-specific expression and chromosomal assignment of the gene. FEBS Lett 377(2): 249-52 (1995).
77. Kang SG, Dimitrova MN, Ortega J, Ginsburg A, Maurizi MR. Human mitochondrial ClpP is a stable heptamer that assembles into a tetradecamer in the presence of ClpX. J Biol Chem 280(42): 35424-32 (2005).
78. Gispert S, Parganlija D, Klinkenberg M, Drose S, Wittig I, Mittelbronn M, et al. Loss of mitochondrial peptidase Clpp leads to infertility, hearing loss plus growth retardation via accumulation of CLPX, mtDNA and inflammatory factors. Hum Mol Genet 22(24): 4871-87 (2013).
79. Kasashima K, Sumitani M, Endo H. Maintenance of mitochondrial genome distribution by mitochondrial AAA+ protein ClpX. Exp Cell Res 318(18): 2335-43 (2012).
80. Fredriksson A, Ballesteros M, Dukan S, Nystrom T. Defense against protein carbonylation by DnaK/DnaJ and proteases of the heat shock regulon. J Bacteriol 187(12): 4207-13 (2005).
81. Janska H, Kwasniak M, Szczepanowska J. Protein quality control in organelles-AAA/FtsH story. Biochim Biophys Acta 1833(2): 381-7 (2013).
82. Gerdes F, Tatsuta T, Langer T. Mitochondrial AAA proteases--towards a molecular understanding of membrane-bound proteolytic machines. Biochim Biophys Acta 1823(1): 49-55 (2012).
83. Kremmidiotis G, Gardner AE, Settasatian C, Savoia A, Sutherland GR, Callen DF. Molecular and functional analyses of the human and mouse genes encoding AFG3L1, a mitochondrial metalloprotease homologous to the human spastic paraplegia protein. Genomics 76(1-3): 58-65 (2001).
84. Steglich G, Neupert W, Langer T. Prohibitins regulate membrane protein degradation by the m-AAA protease in mitochondria. Mol Cell Biol 19(5): 3435-42 (1999).
85. Arlt H, Steglich G, Perryman R, Guiard B, Neupert W, Langer T. The formation of respiratory chain complexes in mitochondria is under the proteolytic control of the m-AAA protease. EMBO J 17(16): 4837-47 (1998).
86. Arlt H, Tauer R, Feldmann H, Neupert W, Langer T. The YTA10-12 complex, an AAA protease with chaperone-like activity in the inner membrane of mitochondria. Cell 85(6): 875-85 (1996).
87. Rainey RN, Glavin JD, Chen HW, French SW, Teitell MA, Koehler CM. A new function in translocation for the mitochondrial i-AAA protease Yme1: import of polynucleotide phosphorylase into the intermembrane space. Mol Cell Biol 26(22): 8488-97 (2006).
88. Maltecca F, Aghaie A, Schroeder DG, Cassina L, Taylor BA, Phillips SJ, et al. The mitochondrial protease AFG3L2 is essential for axonal development. J Neurosci 28(11): 2827-36 (2008).
89. Ferreirinha F, Quattrini A, Pirozzi M, Valsecchi V, Dina G, Broccoli V, et al. Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. J Clin Invest 113(2): 231-42 (2004).
90. Maltecca F, Magnoni R, Cerri F, Cox GA, Quattrini A, Casari G. Haploinsufficiency of AFG3L2, the gene responsible for spinocerebellar ataxia type 28, causes mitochondria-mediated Purkinje cell dark degeneration. J Neurosci 29(29): 9244-54 (2009).
91. Stiburek L, Cesnekova J, Kostkova O, Fornuskova D, Vinsova K, Wenchich L, et al. YME1L controls the accumulation of respiratory chain subunits and is required for apoptotic resistance, cristae morphogenesis, and cell proliferation. Mol Biol Cell 23(6): 1010-23 (2012).
92. Rainbolt TK, Saunders JM, Wiseman RL. YME1L degradation reduces mitochondrial proteolytic capacity during oxidative stress. EMBO Rep 16(1): 97-106 (2014).
93. Atorino L, Silvestri L, Koppen M, Cassina L, Ballabio A, Marconi R, et al. Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia. J Cell Biol 163(4): 777-87 (2003).
94. Vande Walle L, Lamkanfi M, Vandenabeele P. The mitochondrial serine protease HtrA2/Omi: an overview. Cell Death Differ 15(3): 453-60 (2008).
95. Kim DY, Kim KK. Structure and function of HtrA family proteins, the key players in protein quality control. J Biochem Mol Biol 38(3): 266-74 (2005).
96. Moisoi N, Klupsch K, Fedele V, East P, Sharma S, Renton A, et al. Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response. Cell Death Differ 16(3): 449-64 (2009).
97. Martins LM, Morrison A, Klupsch K, Fedele V, Moisoi N, Teismann P, et al. Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol Cell Biol 24(22): 9848-62 (2004).
98. Cilenti L, Ambivero CT, Ward N, Alnemri ES, Germain D, Zervos AS. Inactivation of Omi/HtrA2 protease leads to the deregulation of mitochondrial Mulan E3 ubiquitin ligase and increased mitophagy. Biochim Biophys Acta 1843(7): 1295-307 (2014).
99. Goo HG, Rhim H, Kang S. HtrA2/Omi influences the stability of LON protease 1 and prohibitin, proteins involved in mitochondrial homeostasis. Exp Cell Res 328(2): 456-65 (2014).
100. Krick S, Shi S, Ju W, Faul C, Tsai SY, Mundel P, et al. Mpv17l protects against mitochondrial oxidative stress and apoptosis by activation of Omi/HtrA2 protease. Proc Natl Acad Sci U S A 105(37): 14106-11 (2008).
101. Ding X, Patel M, Shen D, Herzlich AA, Cao X, Villasmil R, et al. Enhanced HtrA2/Omi expression in oxidative injury to retinal pigment epithelial cells and murine models of neurodegeneration. Invest Ophthalmol Vis Sci 50(10): 4957-66 (2009).
102. Fukui H, Moraes CT. The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis? Trends Neurosci 31(5): 251-6 (2008).
103. Alzheimer A, Stelzmann RA, Schnitzlein HN, Murtagh FR. An English translation of Alzheimer’s 1907 paper, “Uber eine eigenartige Erkankung der Hirnrinde”. Clin Anat 8(6): 429-31 (1995).
104. Ripoli C, Cocco S, Li Puma DD, Piacentini R, Mastrodonato A, Scala F, et al. Intracellular accumulation of amyloid-beta (Abeta) protein plays a major role in Abeta-induced alterations of glutamatergic synaptic transmission and plasticity. J Neurosci 34(38): 12893-903.
105. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with lewy bodies. Proc Natl Acad Sci U S A 95(11): 6469-73 (1998).
106. Veereshwarayya V, Kumar P, Rosen KM, Mestril R, Querfurth HW. Differential effects of mitochondrial heat shock protein 60 and related molecular chaperones to prevent intracellular betaamyloid-induced inhibition of complex IV and limit apoptosis. J Biol Chem 281(40): 29468-78 (2006).
107. Jiang YQ, Wang XL, Cao XH, Ye ZY, Li L, Cai WQ. Increased heat shock transcription factor 1 in the cerebellum reverses the deficiency of Purkinje cells in Alzheimer’s disease. Brain Res 1519: 105-11 (2013).
108. Takano M, Yamashita T, Nagano K, Otani M, Maekura K, Kamada H, et al. Proteomic analysis of the hippocampus in Alzheimer’s disease model mice by using two-dimensional fluorescence difference in gel electrophoresis. Neurosci Lett 534: 85-9 (2013).
109. Di Domenico F, Sultana R, Tiu GF, Scheff NN, Perluigi M, Cini C, et al. Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer disease. Brain Res 1333: 72-81 (2010).
110. Walls KC, Coskun P, Gallegos-Perez JL, Zadourian N, Freude K, Rasool S, et al. Swedish Alzheimer mutation induces mitochondrial dysfunction mediated by HSP60 mislocalization of amyloid precursor protein (APP) and beta-amyloid. J Biol Chem 287(36): 30317-27 (2012).
111. Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164(2): 558-61 (2000).
112. Lehnardt S, Schott E, Trimbuch T, Laubisch D, Krueger C, Wulczyn G, et al. A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J Neurosci 28(10): 2320-31 (2008).
113. McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s disease brains. Neurology 38(8): 1285-91 (1988).
114. Noelker C, Morel L, Osterloh A, Alvarez-Fischer D, Lescot T, Breloer M, et al. Heat shock protein 60: an endogenous inducer of dopaminergic cell death in Parkinson disease. J Neuroinflammation 11: 86 (2014).
115. Feng M, Zhang L, Liu Z, Zhou P, Lu X. The expression and release of Hsp60 in 6-OHDA induced in vivo and in vitro models of Parkinson’s disease. Neurochem Res 38(10): 2180-9 (2013).
116. Michaelson DM. APOE epsilon4: the most prevalent yet understudied risk factor for Alzheimer’s disease. Alzheimers Dement 10(6): 861-8 (2014).
117. Osorio C, Sullivan PM, He DN, Mace BE, Ervin JF, Strittmatter WJ, et al. Mortalin is regulated by APOE in hippocampus of AD patients and by human APOE in TR mice. Neurobiol Aging 28(12): 1853-62 (2007).
118. Kogel D, Schomburg R, Copanaki E, Prehn JH. Regulation of gene expression by the amyloid precursor protein: inhibition of the JNK/c-Jun pathway. Cell Death Differ 12(1): 1-9 (2005).
119. Choi J, Forster MJ, McDonald SR, Weintraub ST, Carroll CA, Gracy RW. Proteomic identification of specific oxidized proteins in ApoE-knockout mice: relevance to Alzheimer’s disease. Free Radic Biol Med 36(9): 1155-62 (2004).
120. Pennington K, Peng J, Hung CC, Banks RE, Robinson PA. Differential effects of wild-type and A53T mutant isoform of alpha-synuclein on the mitochondrial proteome of differentiated SH-SY5Y cells. J Proteome Res 9(5): 2390-401 (2010).
121. Licker V, Kovari E, Hochstrasser DF, Burkhard PR. Proteomics in human Parkinson’s disease research. J Proteomics 73(1): 10-29 (2009).
122. Shi M, Jin J, Wang Y, Beyer RP, Kitsou E, Albin RL, et al. Mortalin: a protein associated with progression of Parkinson disease? J Neuropathol Exp Neurol 67(2): 117-24 (2008).
123. Jin J, Hulette C, Wang Y, Zhang T, Pan C, Wadhwa R, et al. Proteomic identification of a stress protein, mortalin/mthsp70/GRP75: relevance to Parkinson disease. Mol Cell Proteomics 5(7): 1193-204 (2006).
124. O’Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer’s disease. Annu Rev Neurosci 34: 185-204.
125. Gray CW, Ward RV, Karran E, Turconi S, Rowles A, Viglienghi D, et al. Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. Eur J Biochem 267(18): 5699-710 (2000).
126. Gupta S, Singh R, Datta P, Zhang Z, Orr C, Lu Z, et al. The Cterminal tail of presenilin regulates Omi/HtrA2 protease activity. J Biol Chem 279(44): 45844-54 (2004).
127. Behbahani H, Pavlov PF, Wiehager B, Nishimura T, Winblad B, Ankarcrona M. Association of Omi/HtrA2 with gamma-secretase in mitochondria. Neurochem Int 57(6): 668-75 (2010).
128. Park HJ, Seong YM, Choi JY, Kang S, Rhim H. Alzheimer’s disease-associated amyloid beta interacts with the human serine protease HtrA2/Omi. Neurosci Lett 357(1): 63-7 (2004).
129. Kooistra J, Milojevic J, Melacini G, Ortega J. A new function of human HtrA2 as an amyloid-beta oligomerization inhibitor. J Alzheimers Dis 17(2): 281-94 (2009).
130. Huttunen HJ, Guenette SY, Peach C, Greco C, Xia W, Kim DY, et al. HtrA2 regulates beta-amyloid precursor protein (APP) metabolism through endoplasmic reticulum-associated degradation. J Biol Chem 282(38): 28285-95 (2007).
131. Park HJ, Kim SS, Seong YM, Kim KH, Goo HG, Yoon EJ, et al. Beta-amyloid precursor protein is a direct cleavage target of HtrA2 serine protease. Implications for the physiological function of HtrA2 in the mitochondria. J Biol Chem 281(45): 34277-87 (2006).
132. Kawamoto Y, Ito H, Kobayashi Y, Suzuki Y, Takahashi R. Localization of HtrA2/Omi immunoreactivity in brains affected by Alzheimer’s disease. Neuroreport 21(17): 1121-5 (2010).
133. Westerlund M, Behbahani H, Gellhaar S, Forsell C, Belin AC, Anvret A, et al. Altered enzymatic activity and allele frequency of OMI/HTRA2 in Alzheimer’s disease. FASEB J 25(4): 1345-52 (2011).
134. Kawamoto Y, Kobayashi Y, Suzuki Y, Inoue H, Tomimoto H, Akiguchi I, et al. Accumulation of HtrA2/Omi in neuronal and glial inclusions in brains with alpha-synucleinopathies. J Neuropathol Exp Neurol 67(10): 984-93 (2008).
135. Jones JM, Albin RL, Feldman EL, Simin K, Schuster TG, Dunnick WA, et al. mnd2: a new mouse model of inherited motor neuron disease. Genomics 16(3): 669-77 (1993).
136. Jones JM, Datta P, Srinivasula SM, Ji W, Gupta S, Zhang Z, et al. Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature 425(6959): 721-7 (2003).
137. Strauss KM, Martins LM, Plun-Favreau H, Marx FP, Kautzmann S, Berg D, et al. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson’s disease. Hum Mol Genet 14(15): 2099-111 (2005).
138. Plun-Favreau H, Klupsch K, Moisoi N, Gandhi S, Kjaer S, Frith D, et al. The mitochondrial protease HtrA2 is regulated by Parkinson’s disease-associated kinase PINK1. Nat Cell Biol 9(11): 1243-52 (2007).
139. Whitworth AJ, Lee JR, Ho VM, Flick R, Chowdhury R, McQuibban GA. Rhomboid-7 and HtrA2/Omi act in a common pathway with the Parkinson’s disease factors Pink1 and Parkin. Dis Model Mech 1(2-3): 168-74; discussion 73 (2008).
140. Tain LS, Chowdhury RB, Tao RN, Plun-Favreau H, Moisoi N, Martins LM, et al. Drosophila HtrA2 is dispensable for apoptosis but acts downstream of PINK1 independently from Parkin. Cell Death Differ 16(8): 1118-25 (2009).
141. Yun J, Cao JH, Dodson MW, Clark IE, Kapahi P, Chowdhury RB, et al. Loss-of-function analysis suggests that Omi/HtrA2 is not an essential component of the PINK1/PARKIN pathway in vivo. J Neurosci 28(53): 14500-10 (2008).
142. Pridgeon JW, Olzmann JA, Chin LS, Li L. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol 5(7): e172 (2007).
143. Butler EK, Voigt A, Lutz AK, Toegel JP, Gerhardt E, Karsten P, et al. The mitochondrial chaperone protein TRAP1 mitigates alpha-Synuclein toxicity. PLoS Genet 8(2): e1002488 (2012).
144. Goard CA, Schimmer AD. Mitochondrial matrix proteases as novel therapeutic targets in malignancy. Oncogene 33(21): 2690-9.